EE9800141A - Amidiini ja isotiokarbamiidi derivaadid lämmastikoksiidi süntaasi inhibiitoritena - Google Patents

Amidiini ja isotiokarbamiidi derivaadid lämmastikoksiidi süntaasi inhibiitoritena

Info

Publication number
EE9800141A
EE9800141A EE9800141A EE9800141A EE9800141A EE 9800141 A EE9800141 A EE 9800141A EE 9800141 A EE9800141 A EE 9800141A EE 9800141 A EE9800141 A EE 9800141A EE 9800141 A EE9800141 A EE 9800141A
Authority
EE
Estonia
Prior art keywords
amidine
nitric oxide
oxide synthase
synthase inhibitors
isothiourea derivatives
Prior art date
Application number
EE9800141A
Other languages
English (en)
Estonian (et)
Inventor
Macdonald James
Shakespeare William
Matz James
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9600275A external-priority patent/SE9600275D0/xx
Priority claimed from SE9603301A external-priority patent/SE9603301D0/xx
Priority claimed from SE9603300A external-priority patent/SE9603300D0/xx
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of EE9800141A publication Critical patent/EE9800141A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Exhaust Gas Treatment By Means Of Catalyst (AREA)
  • Treating Waste Gases (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Gas Separation By Absorption (AREA)
EE9800141A 1995-11-07 1996-11-06 Amidiini ja isotiokarbamiidi derivaadid lämmastikoksiidi süntaasi inhibiitoritena EE9800141A (et)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US627695P 1995-11-07 1995-11-07
US625395P 1995-11-07 1995-11-07
SE9600275A SE9600275D0 (sv) 1996-01-25 1996-01-25 Compounds
SE9603301A SE9603301D0 (sv) 1996-09-11 1996-09-11 Compounds and compositions
SE9603300A SE9603300D0 (sv) 1996-09-11 1996-09-11 Compounds
PCT/SE1996/001425 WO1997017344A1 (en) 1995-11-07 1996-11-06 Amidine and isothiourea derivatives as inhibitors of nitric oxide synthase

Publications (1)

Publication Number Publication Date
EE9800141A true EE9800141A (et) 1998-10-15

Family

ID=27532790

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9800141A EE9800141A (et) 1995-11-07 1996-11-06 Amidiini ja isotiokarbamiidi derivaadid lämmastikoksiidi süntaasi inhibiitoritena

Country Status (24)

Country Link
EP (1) EP0861250B1 (xx)
JP (1) JP2000500132A (xx)
KR (1) KR19990067349A (xx)
AT (1) ATE213241T1 (xx)
AU (1) AU701329B2 (xx)
BR (1) BR9611276A (xx)
CA (1) CA2235301A1 (xx)
CZ (1) CZ139298A3 (xx)
DE (1) DE69619259T2 (xx)
DK (1) DK0861250T3 (xx)
EE (1) EE9800141A (xx)
ES (1) ES2171743T3 (xx)
HU (1) HUP9900142A3 (xx)
IL (1) IL124296A0 (xx)
IS (1) IS4725A (xx)
NO (1) NO982072L (xx)
NZ (1) NZ322227A (xx)
PL (1) PL326554A1 (xx)
PT (1) PT861250E (xx)
SI (1) SI0861250T1 (xx)
SK (1) SK61098A3 (xx)
TR (1) TR199800813T2 (xx)
TW (1) TW458978B (xx)
WO (1) WO1997017344A1 (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998016526A1 (en) * 1996-10-16 1998-04-23 Glaxo Group Limited Tetrahydro-6h-pyrazino[1,2-b]isoquinoline 1,4-diones as apoprotein b-100 inhibitors
SE9701681D0 (sv) 1997-05-05 1997-05-05 Astra Ab New compounds
SE9901901D0 (sv) * 1999-05-26 1999-05-26 Astra Ab Compounds
EA006082B1 (ru) * 2001-12-19 2005-08-25 Х. Лундбекк А/С Производные 3,4-дигидро-1h-изохинолин-2-ила
US6608193B2 (en) * 2001-12-21 2003-08-19 The Procter & Gamble Company Methods for synthesis of amino-tetrahydroisoquinoline ring compounds
CA2494323C (en) * 2002-08-07 2011-01-25 Neuraxon Inc. Amino benzothiazole compounds with nos inhibitory activity
US8710045B2 (en) 2004-01-22 2014-04-29 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the ryanodine receptors
WO2007004959A1 (en) * 2005-07-05 2007-01-11 Astrazeneca Ab New compounds, process for their preparation, intermediates, pharmaceutical compositions and their use in the treatment of 5-ht6 mediated disorders such as alzheimer's disease, cognitive disorders, cognitive impairment associated with schizophrenia, obesity and parkinson's disease
WO2008108445A1 (ja) 2007-03-07 2008-09-12 Takeda Pharmaceutical Company Limited ベンゾオキサゼピン誘導体およびその用途
CN110167946B (zh) 2016-12-23 2022-04-08 第一三共株式会社 具有tnap抑制活性的磺酰胺化合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995009619A2 (en) * 1993-10-04 1995-04-13 The Wellcome Foundation Limited Substituted urea and isothiourea derivatives as no synthase inhibitors
WO1994021621A1 (en) * 1993-03-23 1994-09-29 Astra Aktiebolag Guanidine derivatives useful in therapy
CA2169280A1 (en) * 1993-08-12 1995-02-23 Robert James Gentile Amidine derivatives with nitric oxide synthetase activities
TW397812B (en) * 1995-02-11 2000-07-11 Astra Ab Bicyclic isothiourea derivatives useful in therapy

Also Published As

Publication number Publication date
PT861250E (pt) 2002-07-31
CA2235301A1 (en) 1997-05-15
PL326554A1 (en) 1998-09-28
EP0861250B1 (en) 2002-02-13
DE69619259D1 (de) 2002-03-21
BR9611276A (pt) 1999-01-26
AU7592796A (en) 1997-05-29
MX9803453A (es) 1998-09-30
TR199800813T2 (xx) 1998-07-21
TW458978B (en) 2001-10-11
CZ139298A3 (cs) 1998-09-16
DK0861250T3 (da) 2002-04-29
NZ322227A (en) 1999-11-29
IS4725A (is) 1998-04-24
JP2000500132A (ja) 2000-01-11
AU701329B2 (en) 1999-01-28
HUP9900142A2 (hu) 1999-05-28
EP0861250A1 (en) 1998-09-02
ES2171743T3 (es) 2002-09-16
WO1997017344A1 (en) 1997-05-15
IL124296A0 (en) 1998-12-06
SK61098A3 (en) 1999-01-11
ATE213241T1 (de) 2002-02-15
HUP9900142A3 (en) 2001-08-28
NO982072L (no) 1998-07-03
SI0861250T1 (en) 2002-06-30
KR19990067349A (ko) 1999-08-16
DE69619259T2 (de) 2002-09-19
NO982072D0 (no) 1998-05-06

Similar Documents

Publication Publication Date Title
DK0530087T3 (da) Hidtil ukendte naphthylethylurinstof- og naphthylethylthiourinstofforbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
NO996108L (no) 9-oksinerytromycinderivater
SE0302324D0 (sv) Novel compounds
SE0302323D0 (sv) Novel compounds
SE9803518D0 (sv) Novel compounds
NO984470L (no) Pyrrolopyrrolon-derivater som inhibitorer for neutrofil elastase
ES2134801T3 (es) Monohidrato de hidrocloruro de tiagabina cristalina, su preparacion y su uso.
EE9800141A (et) Amidiini ja isotiokarbamiidi derivaadid lämmastikoksiidi süntaasi inhibiitoritena
DK0634396T3 (da) Aminosyrederivater og deres anvendelse som enkeltfalinaseinhibitorer
DK0490816T3 (da) Fluorforbindelser som aromatase-inhibitorer.
DK624989D0 (da) Hidtil ukendte forbindelser
DE69330601D1 (de) Serotoninergische ergolin derivate
TR199902720T2 (xx) Nitrik oksit sentaz�n�n inhibit�rleri olarak amidin t�revleri.
SE9901901D0 (sv) Compounds
AU2001234314A1 (en) Novel phenylheteroalkylamine derivatives
SE9904676D0 (sv) Novel compounds
IL89538A0 (en) Peptides,their preparation and pharmaceutical compositions containing them
AU7935887A (en) Therapeutic agent for the treatment of peptic ulcer disease
ES2095431T3 (es) N-(isoquinolein-5-il)-sulfonil-azacicloalcanos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
SE9904677D0 (sv) Novel compounds
TW429147B (en) Pharmaceutical composition for the treatment of CNS disorders
SE0000477D0 (sv) Novel compounds
ITMI921855A1 (it) Derivati di catecolammine, processo per la loro preparazione e composizioni farmaceutiche che li contengono
SE9802650D0 (sv) Compounds